Diana M. Chen

发表

Adalimumab efficacy and safety in patients with moderate to severe chronic plaque psoriasis: preliminary findings from a 12-week dose-ranging trial

K. Gordon, C. Leonardi, M. Menter, 2004 .

Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-β1, and increase esophageal smooth muscle contraction.

D. Broide, S. Aceves, R. Dohil, 2010, The Journal of allergy and clinical immunology.

Pimecrolimus cream 1% in the treatment of intertriginous psoriasis: a double-blind, randomized study.

A. Gottlieb, M. Lebwohl, Z. Draelos, 2004, Journal of the American Academy of Dermatology.

The “Understanding Pyoderma Gangrenosum, Review and Assessment of Disease Effects (UPGRADE)” Project: a protocol for the development of the core outcome domain set for trials in pyoderma gangrenosum

K. Thomas, Toshiyuki Yamamoto, H. Herfarth, 2022, Archives of Dermatological Research.

Exophiala Jeanselmei Infection in a Patient with Two Primary Malignancies

Diana M. Chen, 1997 .

Multicenter randomized, double-blind, placebo-controlled, clinical trial of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.

D. Fivenson, V. Werth, A. Pandya, 2008, Archives of dermatology.

Cumulative oral corticosteroid use increases risk of glucocorticoid‐related adverse events in patients with newly diagnosed pemphigus

M. Broder, E. Chang, D. Wormser, 2017, Journal of the American Academy of Dermatology.

An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients.

D. Thiboutot, J. Weiss, G. Webster, 2008, Journal of the American Academy of Dermatology.

Photodynamic therapy with aminolevulinic acid topical solution and visible blue light in the treatment of multiple actinic keratoses of the face and scalp: investigator-blinded, phase 3, multicenter trials.

E. Jeffes, J. Fowler, T. Phillips, 2004, Archives of dermatology.

Age distribution of patients with advanced non-melanoma skin cancer in the United States

C. Reyes, Y. Yim, S. Dacosta Byfield, 2013, Archives of Dermatological Research.

Expanded access study of patients with advanced basal cell carcinoma treated with the Hedgehog pathway inhibitor, vismodegib.

J. Hainsworth, G. Weiss, L. Goldberg, 2014, Journal of the American Academy of Dermatology.

Assessing health-related quality of life for advanced basal cell carcinoma and basal cell carcinoma nevus syndrome: development of the first disease-specific patient-reported outcome questionnaires.

M. Chren, C. Reyes, S. Fosko, 2014, JAMA dermatology.

Impact of a fixed combination of clindamycin phosphate 1.2%-benzoyl peroxide 2.5% aqueous gel on health-related quality of life in moderate to severe acne vulgaris.

D. Thiboutot, G. Webster, E. Merikle, 2010, Cutis.

Rituximab versus Mycophenolate Mofetil in Patients with Pemphigus Vulgaris.

V. Werth, E. Maverakis, D. Mimouni, 2021, The New England journal of medicine.

Novel hyaluronan formulation for preventing acute skin reactions in breast during radiotherapy: a randomized clinical trial

K. Thomas, B. Haley, M. Leitch, 2020, Supportive Care in Cancer.

Efficacy and tolerability of a fixed combination of clindamycin phosphate (1.2%) and low concentration benzoyl peroxide (2.5%) aqueous gel in moderate or severe acne subpopulations.

M. Gold, G. Webster, B. Calvarese, 2009, Journal of drugs in dermatology : JDD.

How patients experience and manage dryness and irritation from acne treatment.

S. Feldman, Diana M. Chen, 2011, Journal of Drugs in Dermatology.